Global Sarcopenia Treatment Market Report By Treatment Type (Protein Supplements, Vitamin B12 Supplements, Vitamin D and Calcium Supplements, Other Treatment Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032

As per this study the Global Sarcopenia Treatment Market was valued USD 3.8 BN (by revenue) in 2022 and is anticipated to reach USD 5.86 BN by 2030 with a CAGR of 5.58%.
 
Sarcopenia is an aging-associated disease which causes loss of skeletal muscle mass, results in decreased strength and aerobic and functional capacity. Effective exercise plan for increasing muscle strength and proper nutrition is majorly used for the treatment of sarcopenia. Supplements of essential nutrients, such as protein, amino acids, creatine, omega 3 acid, vitamin D & B12 and calcium carbonate are also used for sarcopenia treatment.
 
Market Dynamics
 
The growing aging population and increasing interest in preventive healthcare results in rising adoption of supplements is a major factor in boosting the demand for sarcopenia treatment. The growing popularity of supplements for improving the function of growth hormone, testosterone, hydroxyl methylbutyrate and angiotensin converting enzyme inhibitors are also fuelling the market growth. In addition, increasing R&D activities by the manufacturers for the development of new nutrition supplements is also expected to drive the sarcopenia treatment market in upcoming years. However, no new developments for the treatment of sarcopenia are expected to hamper the market growth in upcoming years.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of sarcopenia treatment.
 
Market Segmentation
 
The broad sarcopenia treatment market has been sub-grouped into treatment type and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 

By Treatment Type

• Protein Supplements
• Vitamin B12 Supplements
• Vitamin D and Calcium Supplements
• Other

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other

Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for sarcopenia treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Sarcopenia Treatment Market Share by Region (Representative Graph)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the sarcopenia treatment market include Abbott Nutrition, GSK PLC, Nestle Health Science, Sanofi SA, Bayer AG, Novartis AG, Metagenics LLC, Wellona Pharma, Intas Pharmaceuticals Ltd, Perrigo Company PLC, Dr. Jockers Store. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.